Search results for "Biotechnologie"

showing 10 items of 47 documents

Neuropeptide FF increases M2 activation and self-renewal of adipose tissue macrophages

2017

The quantity and activation state of adipose tissue macrophages (ATMs) impact the development of obesity-induced metabolic diseases. Appetite-controlling hormones play key roles in obesity; however, our understanding of their effects on ATMs is limited. Here, we have shown that human and mouse ATMs express NPFFR2, a receptor for the appetite-reducing neuropeptide FF (NPFF), and that NPFFR2 expression is upregulated by IL-4, an M2-polarizing cytokine. Plasma levels of NPFF decreased in obese patients and high-fat diet-fed mice and increased following caloric restriction. NPFF promoted M2 activation and increased the proliferation of murine and human ATMs. Both M2 activation and increased ATM…

Male0301 basic medicinemedicine.medical_specialty[SDV.BIO]Life Sciences [q-bio]/BiotechnologyUbiquitin-Protein LigasesAdipose tissue macrophagesMafB Transcription FactorAdipose tissueMice TransgenicReceptors Cell SurfaceSelf renewalMice03 medical and health sciencesClinical investigationInternal medicinemedicineAnimalsNeuropeptide FFTranscription factorAdaptor Proteins Signal TransducingCell ProliferationSTAT62. Zero hungerArginasebiologybusiness.industryChemistryMacrophagesProteinsSciences du Vivant [q-bio]/BiotechnologiesGeneral MedicineMacrophage ActivationInterleukin-10Ubiquitin ligaseCell biologyEndocrinology030104 developmental biologyAdipose TissueMAFBbiology.proteinInterleukin-4CorrigendumbusinessOligopeptidesMacrophage proliferationResearch ArticleJournal of Clinical Investigation
researchProduct

Kawasaki disease: Guidelines of Italian Society of Pediatrics, part II - Treatment of resistant forms and cardiovascular complications, follow-up, li…

2018

Abstract This second part of practical Guidelines related to Kawasaki disease (KD) has the goal of contributing to prompt diagnosis and most appropriate treatment of KD resistant forms and cardiovascular complications, including non-pharmacologic treatments, follow-up, lifestyle and prevention of cardiovascular risks in the long-term through a set of 17 recommendations. Guidelines, however, should not be considered a norm that limits the treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient’s condition, and disease severity or individual complications.

MaleDrug ResistanceReviewCoronary Artery Disease030204 cardiovascular system & hematologySeverity of Illness IndexCoronary artery diseaseEfficacy0302 clinical medicineCardiovascular Diseasecoronary artery abnormalitiesChildCoronary artery abnormalitieSocieties MedicalPediatricAnti-Inflammatory Agents Non-Steroidallcsh:RJ1-570Immunoglobulins IntravenousSettore MED/38Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICACardiovascular DiseasesInnovative biotechnologieChild PreschoolPractice Guidelines as TopicFemaleRisk assessmentmedicine.drugHumanmedicine.medical_specialtypediatricsMucocutaneous Lymph Node SyndromeRisk AssessmentFollow-Up Studie03 medical and health sciencesinnovative biotechnologies030225 pediatricsDiabetes mellitusSeverity of illnessmedicineHumansIntensive care medicineIntravenous immunoglobulinAspirinKawasaki diseasebusiness.industryWarfarinlcsh:Pediatricsmedicine.diseasePersonalized medicineInfliximabAspirin; Child; Coronary artery abnormalities; Innovative biotechnologies; Intravenous immunoglobulin; Kawasaki disease; Personalized medicine;Immunoglobulins IntravenouPediatrics Perinatology and Child Healthperinatology and child healthKawasaki diseaseaspirin; child; coronary artery abnormalities; innovative biotechnologies; intravenous immunoglobulin; Kawasaki disease; personalized medicine; pediatrics perinatology and child healthbusinessFollow-Up Studies
researchProduct

Experimental Setup with Chaotic and Periodic Excitations for Cell Growth Studies

2020

The paper presents circuits used for excitation living cells to increase their growth rate. The main novelty is the proposal of using chaotic oscillations for the electromagnetic excitation. The research is in a preliminary phase and no conclusions have been yet derived for applications in biotechnology.

Physicsstimulace buněčného růstuchaotic generators020208 electrical & electronic engineering010401 analytical chemistryPhase (waves)ChaoticNovelty02 engineering and technologybiotechnologie01 natural sciences0104 chemical sciencesharmonic oscillatorscell growth stimulationQuantum electrodynamics0202 electrical engineering electronic engineering information engineeringchaotické generátoryGrowth rateharmonické oscilátoryExcitationChaotic oscillationsHarmonic oscillatorElectronic circuitbiotechnology
researchProduct

Influence of a reducing environment on the bioconversion of fatty acids to lactones and methyl-ketones by microorganisms : cellular and enzymatic app…

2002

National audience

REDUCTIONBIOTECHNOLOGIE[SPI.GPROC] Engineering Sciences [physics]/Chemical and Process Engineering[SDV.IDA]Life Sciences [q-bio]/Food engineering[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process Engineering[SDV.IDA] Life Sciences [q-bio]/Food engineeringComputingMilieux_MISCELLANEOUS
researchProduct

Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry

2022

© 2022 Elsevier Inc.Background/objectives: Long-term efficacy and safety of tocilizumab (TCZ) in adult-onset Still's disease (AOSD) mostly derive from small case series. Herein we report a registry-based study investigating TCZ efficacy and safety in a cohort of patients with AOSD evaluated by clinical and serum inflammatory markers as well as drug retention rate analysis. Methods: This is an international multicentre study analyzing data from patients with AOSD regularly enrolled in the AIDA registry. TCZ efficacy was evaluated between baseline and last follow-up assessment in terms of changes in the Pouchot score and laboratory findings. Drug-retention rate was estimated by the Kaplan-Mei…

RegistrieAdultMaleSettore MED/16 - REUMATOLOGIAInterleukin-6Innovative biotechnologiesTocilizumabAdult-onset Still's diseaseAntibodies Monoclonal HumanizedPersonalized medicineAdult-onset Still's disease; Innovative biotechnologies; Interleukin-6; Personalized medicine; TocilizumabSettore MED/38 - Pediatria Generale E SpecialisticaAnesthesiology and Pain MedicineRheumatologyInnovative biotechnologieStill's diseaseHumansFemaleRegistriesImmunotherapyTocilizumab.Still's Disease Adult-OnsetHuman
researchProduct

Distinguishing between two crus : as easy as picking the right side ? : Effect of expertise on conceptual and perceptual representations of Beaujolai…

2017

L’expertise a été étudiée en psychologie cognitive afin de comprendre les mécanismes psychologiques et les compétences intervenant dans différents domaines d’expertise. Dans le domaine du vin, les quelques études menées suggèrent que les experts organiseraient leurs connaissances autour de « prototypes » de couleur ou de cépage. L’objectif général de cette thèse visait à répondre aux questionnements théoriques concernant les représentations des vins d’experts et de novices, ainsi qu’aux questionnements de la filière concernant les perceptions des vins du Beaujolais. Pour cela, l’effet de l’expertise sur les représentations des vins a été évalué en comparant les performances de trois panels …

Représentation des connaissances[SDV.BIO]Life Sciences [q-bio]/BiotechnologyIngénierie des alimentsWineBiotechnologiesExpertisewine;categorization;expertise;knowledge representationCategorizationKnowledge representationAlimentation et NutritionVin[SDV.IDA]Life Sciences [q-bio]/Food engineeringFood and NutritionFood engineering[SDV.AEN]Life Sciences [q-bio]/Food and NutritionCatégorisation
researchProduct

The Characteristics of initial public offering for innovative small and medium-sized firms: the case of young french bio/medtech firms

2017

The various government measures in favor of innovative SMEs, the number of biotechnology firms listed on the stock exchange over the last ten years, the characteristics of their pre-introduction financing are different factors that justify a particular interest for these firms and their methods of introduction (discount, float, quotation procedure). Different tests of mean difference have significant results. Comparing with a control sample, we found that SME in this sector are listed on the stock exchange faster, by making greater use of the open-price offer procedure (OPO) and are subject to greater prior financing by financial stockholders. Although the ownership of the capital and the d…

Société de biotechnologie[SHS.GESTION]Humanities and Social Sciences/Business administration[ SHS.ECO ] Humanities and Social Sciences/Economies and financesInnovative SMEsIPO[SHS.ECO]Humanities and Social Sciences/Economics and Finance[ SHS.GESTION ] Humanities and Social Sciences/Business administrationintroduction en bourse[SHS.ECO] Humanities and Social Sciences/Economics and Finance[SHS.GESTION] Humanities and Social Sciences/Business administrationBiotechnology firmsPme innovante
researchProduct

Increased electron donor and electron acceptor characters enhance the adhesion between oil droplets and cells of Yarrowia lipolytica as evaluated by …

2003

The adhesion of methyl ricinoleate droplets to cells of the yeast Yarrowia lipolytica was investigated. A new cytometric method, relying on the double staining of fatty globules with Nile Red and of cells with Calcofluor, enabled us to quantify methyl ricinoleate droplet adhesion to cells precultured on a hydrophilic or on a hydrophobic carbon source. In this last case, droplet adsorption was enhanced and a MATS (microbial adhesion to solvents) test revealed that this increase was due to Lewis acid-base interactions and not to an increase in the hydrophobic properties of the cell surface. These preliminary results demonstrate that the developed cytometric method is promising for various app…

Yarrowia lipolyticaMicroscopy ConfocalFatty AcidsFungiBiotechnologieAdhesivenessYarrowiaFlow CytometryLife sciencesMethyl ricinoleateLewis acidElectron TransportMicroscopy FluorescenceSurface propertiesSciences du vivantAdsorptionRicinoleic AcidsOilsCytometryBiotechnology
researchProduct

Gene flow from oilseed rape to weedy species

2003

The assessment of the likelihood of transgene spread from cultivated species to their wild relatives is relevant for oilseed rape (Brassica napus, AACC, 2n=38) as it is partially allogamous and pre...

[SDE] Environmental Sciences0106 biological sciences0303 health sciencesBIOTECHNOLOGIEbiologyTransgene[SDV]Life Sciences [q-bio]Brassicafood and beveragesSoil ScienceAMELIORATION DES PLANTESbiology.organism_classification01 natural sciencesGene flow[SDV] Life Sciences [q-bio]Interspecific hybridization03 medical and health sciencesBotany[SDE]Environmental SciencesAgronomy and Crop ScienceCOLZAComputingMilieux_MISCELLANEOUS030304 developmental biology010606 plant biology & botany
researchProduct

Avis en réponse à la saisine HCB - dossier C/NL/06/01_001. Paris, le 17 octobre 2018

2018

Le Haut Conseil des biotechnologies (HCB) a été saisi le 14 août 2018 par les autorités compétentes françaises (le ministère de l’Agriculture et de l’Alimentation) d’une demande d’avis relative au dossier C/NL/06/01_001 de demande de renouvellement d’autorisation de mise sur le marché de la lignée d’oeillets génétiquement modifiés 123.8.12 (identificateur unique FLO- 40689-6) à des fins d’importation et de commercialisation de fleurs coupées. Ce dossier a été déposé par la société Suntory Flowers Limited auprès des autorités compétentes néerlandaises sur le fondement de la directive 2001/18/CE. Conformément à cette directive, la Commission européenne a adressé le rapport d’évaluation des Pa…

[SDE] Environmental Sciences[SDV.BIO]Life Sciences [q-bio]/Biotechnology[SPI.GPROC] Engineering Sciences [physics]/Chemical and Process Engineering[SDV]Life Sciences [q-bio][SDV.GEN] Life Sciences [q-bio]/Genetics[SDV.GEN.GA] Life Sciences [q-bio]/Genetics/Animal geneticsorganisme génétiquement modifié[SHS]Humanities and Social Sciences[SDV.IDA]Life Sciences [q-bio]/Food engineering[SDV.BV]Life Sciences [q-bio]/Vegetal Biology[SDV.BV] Life Sciences [q-bio]/Vegetal Biology[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process EngineeringalimentationHaut conseil des biotechnologies[SDV.GEN]Life Sciences [q-bio]/GeneticsimportationOGM[SDV.IDA] Life Sciences [q-bio]/Food engineering[SDV.BIO] Life Sciences [q-bio]/Biotechnologyculture[SDV] Life Sciences [q-bio][SDV.GEN.GA]Life Sciences [q-bio]/Genetics/Animal geneticsplante[SDE]Environmental Sciencesexpertise[SHS] Humanities and Social Sciencesévaluation des risques
researchProduct